@article{Navneet S. Majhail_Elizabeth Murphy_Purushottam Laud_Jaime M. Preussler_Ellen M. Denzen_Beatrice Abetti_Alexia Adams_RaeAnne Besser_Linda J. Burns_Jan Cerny_Rebecca Drexler_Theresa Hahn_Lensa Idossa_Balkrishna Jahagirdar_Naynesh Kamani_Alison Loren_Deborah Mattila_Joseph McGuirk_Heather Moore_Jana Reynolds_Wael Saber_Lizette Salazar_Barry Schatz_Patrick Stiff_John R. Wingard_Karen L Syrjala_K. Scott Baker_2019, place={Pavia, Italy}, title={Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors}, volume={104}, url={https://haematologica.org/article/view/8884}, DOI={10.3324/haematol.2018.203919}, abstractNote={Survivorship Care Plans (SCPs) may facilitate long-term care for cancer survivors, but their effectiveness has not been established in hematopoietic cell transplantation recipients. We evaluated the impact of individualized SCPs on patient-reported outcomes among transplant survivors. Adult (≥18 years at transplant) survivors who were 1-5 years post transplantation, proficient in English, and without relapse or secondary cancers were eligible for this multicenter randomized trial. SCPs were developed based on risk-factors and treatment exposures using patient data routinely submitted by transplant centers to the Center for International Blood and Marrow Transplant Research and published guidelines for long-term follow up of transplant survivors. Phone surveys assessing patient-reported outcomes were conducted at baseline and at 6 months. The primary end point was confidence in survivorship information, and secondary end points included cancer and treatment distress, knowledge of transplant exposures, health care utilization, and health-related quality of life. Of 495 patients enrolled, 458 completed a baseline survey and were randomized (care plan=231, standard care=227); 200 (87%) and 199 (88%) completed the 6-month assessments, respectively. Patients’ characteristics were similar in the two arms. Participants on the care plan arm reported significantly lower distress scores at 6 months and an increase in the Mental Component Summary quality of life score assessed by the Short Form 12 (SF-12) instrument. No effect was observed on the end point of confidence in survivorship information or other secondary outcomes. Provision of individualized SCPs generated using registry data was associated with reduced distress and improved mental domain of quality of life among 1-5 year hematopoietic cell transplantation survivors. Trial registered at <em><a href="http://clinicaltrials.gov">clinicaltrials.gov</a> 02200133</em&gt;.}, number={5}, journal={Haematologica}, author={Navneet S. Majhail and Elizabeth Murphy and Purushottam Laud and Jaime M. Preussler and Ellen M. Denzen and Beatrice Abetti and Alexia Adams and RaeAnne Besser and Linda J. Burns and Jan Cerny and Rebecca Drexler and Theresa Hahn and Lensa Idossa and Balkrishna Jahagirdar and Naynesh Kamani and Alison Loren and Deborah Mattila and Joseph McGuirk and Heather Moore and Jana Reynolds and Wael Saber and Lizette Salazar and Barry Schatz and Patrick Stiff and John R. Wingard and Karen L Syrjala and K. Scott Baker}, year={2019}, month={Apr.}, pages={1084-1092} }